{"id":56075,"date":"2023-04-21T00:04:19","date_gmt":"2023-04-20T22:04:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/"},"modified":"2023-04-21T00:04:19","modified_gmt":"2023-04-20T22:04:19","slug":"ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/","title":{"rendered":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call"},"content":{"rendered":"<div>\n<p class=\"bwalignl\">CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) will issue its first quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Monday, May 8, 2023. A conference call to discuss those earnings will be held on Tuesday, May 9, 2023 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).<\/p>\n<p>\nThe dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ventasreit.com&amp;esheet=53385120&amp;newsitemid=20230420006009&amp;lan=en-US&amp;anchor=www.ventasreit.com&amp;index=1&amp;md5=526e0c70c4c909baa28946be8c942148\" rel=\"nofollow noopener\" shape=\"rect\">www.ventasreit.com<\/a>.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/5\/Ventas_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg\"><\/a><\/p>\n<p>\nA telephonic replay will be available at (800) 770-2030 (or +1 (647) 362-9199 for international callers), passcode 7655497, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ventasreit.com&amp;esheet=53385120&amp;newsitemid=20230420006009&amp;lan=en-US&amp;anchor=www.ventasreit.com&amp;index=2&amp;md5=cf691e7c4492a7762e5c32b029168a91\" rel=\"nofollow noopener\" shape=\"rect\">www.ventasreit.com<\/a>.<\/p>\n<p>\n<b><span class=\"bwuline\">About Ventas<\/span><\/b><\/p>\n<p>\nVentas Inc., an S&amp;P 500 company, operates at the intersection of two large and dynamic industries \u2013 healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research &amp; innovation properties; medical office &amp; outpatient facilities, hospitals and other healthcare real estate. A globally recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nVentas, Inc.<br \/>\n<br \/>BJ Grant<br \/>\n<br \/>(877) 4-VENTAS<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) will issue its first quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Monday, May 8, 2023. A conference call to discuss those earnings will be held on Tuesday, May 9, 2023 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56075","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) will issue its first quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Monday, May 8, 2023. A conference call to discuss those earnings will be held on Tuesday, May 9, 2023 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T22:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call\",\"datePublished\":\"2023-04-20T22:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420006009\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/\",\"name\":\"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420006009\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"datePublished\":\"2023-04-20T22:04:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420006009\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420006009\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) will issue its first quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Monday, May 8, 2023. A conference call to discuss those earnings will be held on Tuesday, May 9, 2023 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-20T22:04:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call","datePublished":"2023-04-20T22:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/"},"wordCount":276,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/","url":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/","name":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg","datePublished":"2023-04-20T22:04:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230420006009\/en\/282462\/21\/Ventas_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ventas-announces-first-quarter-2023-earnings-release-date-and-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ventas Announces First Quarter 2023 Earnings Release Date and Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56075"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56075\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}